Literature DB >> 3500503

Inhibition of T cell cytolytic potential by concanavalin A: a result of activation?

A M Miltenburg1, M E Meijer-Paape, M R Daha, L C Paul.   

Abstract

We investigated the effects of concanavalin A (Con A) on T cell-mediated lympholysis. Human cytotoxic T cell lines were generated from peripheral blood and these lines were shown to lyse lectin-coated K562 target cells. Addition of soluble Con A to the assay resulted in a dose-dependent inhibition of the cytolysis. Preincubation experiments demonstrated that this inhibitory effect was exerted at the effector cell level. F(ab')2 fragments of WT32, a monoclonal antibody against T3, blocked the cytolysis of Con A-preincubated K562 target cells to a large extent. We further showed that Con A strongly inhibited the cytolysis exerted by alloantigen-specific, major histocompatibility complex (MHC)-restricted cytotoxic T cell lines against their specific targets. On the other hand, Con A had no clear inhibitory effect on the cytotoxicity of freshly isolated peripheral blood mononuclear cells against K562 target cells. We hypothesize that Con A-induced inhibition of cytotoxicity may be explained by a direct triggering of the lytic potential of activated T cells.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3500503     DOI: 10.1111/j.1365-3083.1987.tb02289.x

Source DB:  PubMed          Journal:  Scand J Immunol        ISSN: 0300-9475            Impact factor:   3.487


  2 in total

1.  Cytolytic activity in T cell clones derived from human synovial rheumatoid membrane: inhibition by synovial fluid.

Authors:  A M Miltenburg; J M Van Laar; P De Kuiper; M R Daha; F C Breedveld
Journal:  Clin Exp Immunol       Date:  1990-12       Impact factor: 4.330

2.  Regulation of C3 and factor H synthesis of human glomerular mesangial cells by IL-1 and interferon-gamma.

Authors:  M E van den Dobbelsteen; V Verhasselt; J G Kaashoek; J J Timmerman; W E Schroeijers; C L Verweij; F J van der Woude; L A van Es; M R Daha
Journal:  Clin Exp Immunol       Date:  1994-01       Impact factor: 4.330

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.